1996
DOI: 10.1002/(sici)1098-2752(1996)17:9<495::aid-micr4>3.0.co;2-c
|View full text |Cite
|
Sign up to set email alerts
|

Actions of glucocorticosteroids on ischemic-reperfused muscle and cutaneous tissue

Abstract: Ischemia-reperfusion injury represents a complex series of vascular and cellular events that resembles an acute inflammatory reaction within the reperfused tissue. This article provides an overview of glucocorticosteroid effects on cells and tissues involved in inflammatory reaction following ischemia-reperfusion of muscle and cutaneous tissue. Glucocorticosteroids exert a variety of effects that influence the microcirculation. These effects include leukocyte recruitment, reduction of vascular permeability, in… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
5
0

Year Published

1998
1998
2024
2024

Publication Types

Select...
7

Relationship

1
6

Authors

Journals

citations
Cited by 11 publications
(5 citation statements)
references
References 55 publications
0
5
0
Order By: Relevance
“…By activating these GRs, glucocorticoids may affect reperfusion injury in a multitude of ways, including inhibition of leucocyte recruitment ( Perretti & Flower, 1993 ; Pitzalis et al ., 1997 ), reduction of vascular permeability ( Evans & Whittle, 2003 ; Romero et al ., 2003 ; Su et al ., 2004 ), inhibition of formation of cytokines or other mediators ( Almawi et al ., 1998 ; Turesin et al ., 2003 ) and modulation of enzyme systems involved in inflammation ( Koehler et al ., 1990 ; Kleinert et al ., 1996 ; Wallerath et al ., 2004 ). Potential mechanisms may involve modulation of neutrophil and endothelial function ( Korompilias et al ., 1996 ; Tjandra et al ., 1996 ; Takahira et al ., 2001 ), inhibition of formation of arachidonic acid products ( Turesin et al ., 2003 ) and attenuation of lipid peroxidation of biological membranes through membrane stabilization and scavenging of toxic‐free radicals ( Korompilias et al ., 1996 ; Marumo et al ., 1998 ). Here, treatment with dexamethasone totally suppressed the increase in vascular permeability, neutrophil influx and haemorrhage induced by reperfusion of the ischaemic SMA.…”
Section: Discussionmentioning
confidence: 99%
“…By activating these GRs, glucocorticoids may affect reperfusion injury in a multitude of ways, including inhibition of leucocyte recruitment ( Perretti & Flower, 1993 ; Pitzalis et al ., 1997 ), reduction of vascular permeability ( Evans & Whittle, 2003 ; Romero et al ., 2003 ; Su et al ., 2004 ), inhibition of formation of cytokines or other mediators ( Almawi et al ., 1998 ; Turesin et al ., 2003 ) and modulation of enzyme systems involved in inflammation ( Koehler et al ., 1990 ; Kleinert et al ., 1996 ; Wallerath et al ., 2004 ). Potential mechanisms may involve modulation of neutrophil and endothelial function ( Korompilias et al ., 1996 ; Tjandra et al ., 1996 ; Takahira et al ., 2001 ), inhibition of formation of arachidonic acid products ( Turesin et al ., 2003 ) and attenuation of lipid peroxidation of biological membranes through membrane stabilization and scavenging of toxic‐free radicals ( Korompilias et al ., 1996 ; Marumo et al ., 1998 ). Here, treatment with dexamethasone totally suppressed the increase in vascular permeability, neutrophil influx and haemorrhage induced by reperfusion of the ischaemic SMA.…”
Section: Discussionmentioning
confidence: 99%
“…Glucocorticoids have a plethora of effects, including inhibition of lipid peroxidation, inhibition of formation of arachidonic acid products and modulation of neutrophil and endothelial function (19). Chronic glucocorticoid administration is known to alter protein metabolism (7,8).…”
Section: Hormones and Hsp Inductionmentioning
confidence: 99%
“…These include the postoperative administration of topical agents such as fibrin, soluble mediators and growth factors (eg, recombinant human vascular endothelial growth factor), 1,2 and antiischemic pharmacotherapeutics (nitroglycerine, trolamine salicylate, and nifedipine). 3 Systemically administered agents with some protective effect in ischemic tissue have been tested to include hyperbaric oxygen, 4 corticosteroids, 5 thrombolytics, 6 free radical scavengers, 7 and vasoactive agents (potassium channel agonists like nicorandil, prostacyclin, and other prostanoid modifiers). 8,9 However, no single pharmacological intervention has proven consistently effective.…”
mentioning
confidence: 99%